BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  New and Updated Data for Merck’s KEYTRUDA (pembrolizumab) and Updated Data on LYNPARZA (olaparib) in Multiple Breast Cancer Subtypes to Be Presented at the 2017 San Antonio Breast Cancer Symposium (SABCS)

  In addition to the presentation of KEYTRUDA data at SABCS, updated data on LYNPARZA being co-developed and co-commercialized with AstraZeneca, will be presented.

  November 30, 2017

   · 

  33 min read
• Drug Development

  Solid Biosciences Initiates Clinical Trial for Gene Transfer Candidate SGT-001 in Patients With Duchenne Muscular Dystrophy

  Interim analysis anticipated in the first half of 2019.

  November 30, 2017

   · 

  5 min read
• Edico Genome Launches DRAGEN Complete Suite on AWS Marketplace, Including Enhanced Second-Generation Germline and Somatic Pipelines

  Today at AWS re:Invent, Edico Genome revealed its DRAGEN CS on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN’s applications for NGS data analysis in one click.

  November 30, 2017

   · 

  4 min read
• Biotech Beach

  Epic Sciences Launches Metastatic Breast Cancer Circulating Tumor Cell Panel

  The Epic breast cancer panel is the most comprehensive breast cancer biomarker panel available for CTCs within a blood sample.

  November 30, 2017

   · 

  2 min read
• Business

  AMRI Doubles Bulk API Aseptic Manufacturing Capacity

  The addition of a new multipurpose aseptic API line at AMRI’s facility in Valladolid, Spain, enhances capacity at the site and complements its other aseptic API manufacturing plants in Bon Encontre and Tonneins, France.

  November 30, 2017

   · 

  2 min read
• 

  FDA

  Cordis and Medinol Announce FDA Approval of the Innovative EluNIR Drug-Eluting Stent System

  Cordis today announced FDA approval of the EluNIR drug-eluting stent for the treatment of patients with narrowing or blockages to their coronary arteries

  November 30, 2017

   · 

  4 min read
• Pharm Country

  Mitsubishi Tanabe Pharma America Announces Addition of RADICAVA (edaravone) to U.S. Department of Veterans Affairs National Formulary

  The VANF criteria follow the FDA’s approved labeling, and all VA requests will be determined at the national level by a single team of experts, enabling consistency across the system.

  November 30, 2017

   · 

  7 min read
• Biotech Beach

  Simulations Plus Releases ADMET Predictor Version 8.5

  New HTPK Simulation Module allows chemists to screen compound libraries using novel approach.

  November 30, 2017

   · 

  4 min read
• Deals

  Myomo Announces Pricing of Public Offering

  The warrants have an exercise price of $2.95 per share, are immediately exercisable and will expire on December 4, 2022.

  November 30, 2017

   · 

  3 min read
• Biotech Bay

  Ultragenyx to Highlight Pipeline at Analyst and Investor Day on December 4

  Analyst and Investor Day will be an opportunity to provide updates on our clinical and early stage pipeline, including the newly acquired gene therapy programs, as well as a commercial overview.

  November 30, 2017

   · 

  2 min read